GLP-1 Users Get Surgery for 'Ozempic Ears' Side Effect
Patients using GLP-1 weight loss medications are seeking surgical interventions to correct 'Ozempic ears' and other facial aging effects.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
GLP-1 weight loss led to new facial aging challenges, including "floppy" earlobes. Some users sought surgery to fix these "Ozempic ears" while others focused on preventing "Ozempic face."
Epilogue added 67d ago, after coverage quieted.
The brief
A new trend in medical aesthetics is emerging as individuals using GLP-1 weight loss medications seek surgical corrections for a condition referred to as 'Ozempic ears.' According to reports from The Daily Beast and the New York Post, patients are undergoing procedures to fix earlobes that have become 'floppy' and 'old-looking' following significant weight loss. These surgical interventions are aimed at addressing the physical changes in the earlobes that occur as a side effect of the rapid weight loss associated with these medications. The phenomenon is part of a broader set of aesthetic challenges involving the face and skin quality after GLP-1 use. The coverage of this trend is highlighted by an exclusive report from the New York Post, which focuses specifically on the surgical pursuit to repair the earlobes. The Daily Beast further validates this trend by reporting that users are actively getting surgery for this specific side effect.
Additionally, Halton Hills News reports that GLP weight loss is creating new and distinct facial aging challenges for patients. Yahoo has also contributed to the discourse by noting that there is an ongoing process of learning how to prevent the separate but related phenomenon known as 'Ozempic face.' Understanding this trend requires context regarding the systemic impact of GLP-1 medications on body composition. While these drugs are used for weight loss, the speed and volume of weight reduction can lead to a loss of subcutaneous fat and skin elasticity. This process manifests in various parts of the head and neck, leading to the 'floppy' appearance of the earlobes mentioned in the New York Post and the general facial aging described by Halton Hills News. The industry is currently attempting to identify preventative measures for these changes, as noted in the coverage from Yahoo regarding 'Ozempic face.' Moving forward, observers should watch for more detailed medical guidance on preventing these facial changes before they require surgical intervention.
Since Yahoo reports that experts are currently learning how to prevent 'Ozempic face,' future developments may include new preventative protocols. The focus remains on the surgical outcomes for those already experiencing 'Ozempic ears' and whether these procedures become a standardized part of the GLP-1 patient journey as more people undergo rapid weight loss. Coverage does not yet specify the long-term success rates or the specific types of surgical techniques being employed to fix the earlobes.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 108d ago.
Quick answers
What are 'Ozempic ears'?
They are 'floppy,' old-looking earlobes that occur as a side effect of weight loss from GLP-1 medications.
How are people treating this side effect?
According to the New York Post and The Daily Beast, people are getting surgery to fix their earlobes.
Is this the only facial side effect reported?
No, coverage from Yahoo and Halton Hills News also mentions 'Ozempic face' and general facial aging challenges.
Coverage (4)
- We're learning how to prevent 'Ozempic face' Yahoo · 156d ago
- Exclusive | People are getting surgery to fix their ‘floppy,’ old-looking ‘Ozempic earlobes’ after GLP-1 weight loss New York Post · 156d ago
- GLP weight loss creates new facial aging challenges! Halton Hills News · 156d ago
- GLP-1 Users Get Surgery for 'Ozempic Ears' Side Effect The Daily Beast · 156d ago
Topics
Related trends
DJ Khaled reflects on using GLP-1s in 90-pound weight loss journey: ‘I needed help’
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.
Some people are having hallucinations and other psychotic symptoms after stopping GLP-1 drugs
Two case reports describe men who developed psychosis after stopping tirzepatide, adding to questions about the psychiatric effects of discontinuing GLP-1 drugs.
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
FDA tells GLP-1 makers to warn of potential vision loss side effect
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
Hers Health, Inc. Reports Third Quarter 2026 Financial Results
Hims & Hers Health reported Q3 2026 revenue of $401.6 million, up 69% year over year, but narrowed its full-year revenue guidance and cut its adjusted EBITDA forecast, sending shares down sharply.